WGS - NASDAQ

GeneDx Holdings Corp.

WGS·NASDAQ

$55.75

+5.2%

HealthcareMedical - Healthcare Information Services

GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$1.66B

EPS-0.7300

P/E Ratio-76.37

Earnings Date08/04/2026

wgs

Total Assets

Last Annual Value

570.19M

3-Year CAGR

5-Year CAGR

18%

10-Year CAGR

Adjust for Inflation

GeneDx Holdings Corp. Competitors Analysis of Total Assets

WGS · NASDAQ

Company	Total Assets	CAGR 3Y	CAGR 5Y	CAGR 10Y
GeneDx Holdings Corp. NASDAQ:WGS	570.19M	10.8%	0.6%	N/A
Privia Health Group, Inc. NASDAQ:PRVA	1.37B	11.1%	14.8%	N/A
NewAmsterdam Pharma Company N.V. NASDAQ:NAMS	769.28M	30.4%	62.5%	N/A
Kymera Therapeutics, Inc. NASDAQ:KYMR	1.74B	44.7%	23.5%	N/A
Hinge Health, Inc. NYSE:HNGE	744.76M	6.2%	N/A	N/A
Viking Therapeutics, Inc. NASDAQ:VKTX	715.73M	24.8%	27.7%	47.6%
Oscar Health, Inc. NYSE:OSCR	6.33B	20.7%	13.7%	N/A
Immunovant, Inc. NASDAQ:IMVT	957.01M	33.1%	18.3%	N/A
TransMedics Group, Inc. NASDAQ:TMDX	1.07B	14.8%	51.3%	33.8%
Crinetics Pharmaceuticals, Inc. NASDAQ:CRNX	1.14B	21.4%	26.5%	56.9%
Option Care Health, Inc. NASDAQ:OPCH	3.46B	1.3%	3.4%	19.0%

GeneDx Holdings Corp. Fair Value Envelope

WGS · NASDAQ

Our analysis suggests that WGS has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $55.7506, this represents a potential HIDDEN relative to our calculated worth for GeneDx Holdings Corp..

HIDDEN

Intrinsic Value

Current Price: $55.7506

Related Guides

Blog Categories

Continue your WGS research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.